NCT03176914 Testing the Effectiveness of a Modified Community Model in Improving Child Health Outcomes in Mashonaland East, Zimbabwe Status COMPLETED Phase NA
NCT03165981 Fever After Simultaneous Versus Sequential Vaccination in Young Children Status COMPLETED Phase PHASE4
NCT03075111 Host-based Immunoassay for Differentiating Bacterial From Viral Infections (Post-marketing Study of ImmunoXpert™ - SPIRIT Study) Status COMPLETED Phase N/A
NCT03052088 Diagnostic Accuracy of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Status COMPLETED Phase N/A
NCT02979626 Evaluation of Moderate to Severe Influenza Outcomes in Children Status COMPLETED Phase N/A
NCT02977481 Ear Temperature as Predictor of Rectal Temperature Measured With Modern Devices in the Emergency Department. Status COMPLETED Phase N/A
NCT02948283 Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE1
NCT02937129 Clinical Accuracy and Reliability of Infrared Tympanic Thermometer in an Adult Emergency Department Status COMPLETED Phase N/A
NCT02926625 Universal Versus Conditional Three-day Follow-up Visit for Children With Unclassified Fever Status COMPLETED Phase PHASE4
NCT02903342 Fever and Febrile Support for Parents and Carers of Children 2016 Status COMPLETED Phase NA
NCT02901990 Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine Status COMPLETED Phase N/A
NCT02900079 Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers Status WITHDRAWN Phase N/A
NCT02900066 Filter Paper Blood Spots Collected During Fever as a Source for Post-travel Diagnosis in Travelers Status COMPLETED Phase N/A
NCT02898948 Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department Status COMPLETED Phase N/A
NCT02871219 Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma Status COMPLETED Phase PHASE2